Literature DB >> 8651374

Antigen-specific immunosuppression in paracoccidioidomycosis.

G Benard1, M A Hong, G M Del Negro, L Batista, M A Shikanai-Yasuda, A J Duarte.   

Abstract

To characterize the immune dysfunction associated with paracoccidioidomycosis, we studied the in vitro lymphocyte reactivity to phytohemagglutinin (PHA), pokeweed mitogen (PWM), a Candida albicans antigen (CMA), and a Paracoccidioides brasiliensis antigen (PbAg) in 32 patients with the acute and the chronic form of the disease before or during the initial phase of treatment and after clinical cure. We also studied, as controls, 30 healthy individuals, 15 of them immune to P. brasiliensis. Results showed a strong hyporesponsiveness to the PbAg while responses to mitogens and CMA were comparable with those of controls. Patients with the acute form of the disease (usually more severe) had more marked PbAg hyporesponsiveness than those with the chronic form. After patients' clinical cure, PbAg proliferative responses were similar to controls and greater than those seen before pretreatment. Changes in other parameters were also seen in the treated patients; skin test anergy to paracoccidioidin, high levels of anti-P. brasiliensis antibodies, leukocytosis, and eosinophilia. These changes were usually more intense in patients with the acute form of the disease. The post-treatment CD4+, CD8+, and total lymphocyte counts were similar to those of controls. Correlation between these parameters and the lymphoproliferative responses to the various stimuli was only found with PbAg: PbAg responses correlated inversely with eosinophil and anti P. brasiliensis antibody levels. Overall, our results demonstrate an antigen-specific-cellular immunity defect, which is reversible with treatment and possibly related to a T helper cell-2 pattern of immune response during active disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651374     DOI: 10.4269/ajtmh.1996.54.7

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

1.  Involvement of regulatory T cells in the immunosuppression characteristic of patients with paracoccidioidomycosis.

Authors:  Maria Carolina Ferreira; Rômulo Tadeu Dias de Oliveira; Rosiane Maria da Silva; Maria Heloisa Souza Lima Blotta; Ronei Luciano Mamoni
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses.

Authors:  C Y Hung; N M Ampel; L Christian; K R Seshan; G T Cole
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Altered ex vivo expression of caspase 8, caspase 9, and Bcl-2 is associated with T-cell hyporeactivity in patients with paracoccidioidomycosis.

Authors:  Camila R Cacere; Maria J S Mendes-Giannini; Antonio Carlos F do Valle; Alberto J S Duarte; Gil Benard
Journal:  Clin Vaccine Immunol       Date:  2009-04-22

4.  Characterization of the cellular immune function of patients with chronic mucocutaneous candidiasis.

Authors:  D de Moraes-Vasconcelos; N M Orii; C C Romano; R Y Iqueoka; A J Duarte
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

5.  Atypical serological response marked by a lack of detectable anti-gp43 antibodies in a patient with disseminated paracoccidioidomycosis.

Authors:  Mônica S M Vidal; Gil Benard; Thales de Brito; Kátia C Dantas; Cristiane N Pereira; Francisco O S França; Ana M G da Silva; José E C Martins
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

6.  Humoral immune response in chromoblastomycosis during and after therapy.

Authors:  P Esterre; M Jahevitra; A Andriantsimahavandy
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

7.  Interferon-gamma and tumor necrosis factor-alpha determine resistance to Paracoccidioides brasiliensis infection in mice.

Authors:  J T Souto; F Figueiredo; A Furlanetto; K Pfeffer; M A Rossi; J S Silva
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

8.  Severe Paracoccidioidomycosis in a 14-Year-Old Boy.

Authors:  L P Ruas; R M Pereira; F G Braga; X T Lima; R L Mamoni; M L Cintra; A Z Schreiber; V L G Calich; M H S L Blotta
Journal:  Mycopathologia       Date:  2016-06-30       Impact factor: 2.574

Review 9.  An overview of the immunopathology of human paracoccidioidomycosis.

Authors:  Gil Benard
Journal:  Mycopathologia       Date:  2008 Apr-May       Impact factor: 2.574

10.  Increased immunoglobulin G anti-Paracoccidioides brasiliensis serum antibody avidity as a predictor of favorable posttherapeutic evolution in paracoccidioidomycosis.

Authors:  Márcia Yoshida; Maria Carmen Arroyo Sanchez; Maria Aparecida Shikanai-Yasuda
Journal:  Clin Vaccine Immunol       Date:  2009-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.